CapsoVision Inc CV
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2025-07-02 |
| Shares Out. | 49,960,000 |
| Website | capsovision.com/ ↗ |
| Phone | 13026587581 |
| Employees | 99 |
| Revenue | $2.8M |
| Gross Profit | $1.3M |
| Net Income | -$7.0M |
| Free Cash Flow | -$24.5M |
| Total Assets | $25.9M |
| Total Liabilities | $5.7M |
| Equity | $20.2M |
About CapsoVision Inc
CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.
CapsoVision Inc is a publicly traded company under the ticker symbol CV on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
9 analysts (2026-07-01)